Brain 'trick' Offers Treatment Hope For Alzheimer's

Main Category: Alzheimer's / Dementia
Article Date: 03 Jul 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (5 votes)

Healthcare Prof:4 stars

4 (4 votes)


Scientists in the UK and Canada have made a significant step forward in the search for new drugs to treat Alzheimer's disease.

An ageing population means that neurodegeneration, such as Alzheimer's disease, is one of the major health problems in the developed world. But researchers at the University of York and Simon Fraser University in Burnaby, British Columbia, have designed an enzyme inhibitor which could 'trick' the brain and so help to halt neurodegeneration.

The research is published in the latest issue of Nature Chemical Biology.

One of the causes of neurodegeneration is a modification to the protein 'tau', which helps to maintain the stability of neurones in the brain, causing them to form aggregates termed 'tangles'.

These diseases, or 'tauopathies' are believed to be caused by a form of the protein tau which has been excessively modified with phosphate.

By studying the chemistry and structure of relevant enzymes, the research teams at York, led by Professor Gideon Davies, and Simon Fraser, led by Professor David Vocadlo, have designed an enzyme inhibitor that prevents the phosphorylation of tau in animal models. They have effectively tricked the brain's own enzymes into installing a sugar on to tau in place of the detrimental phosphates.

The enzyme inhibitor, termed a 'thiazoline', developed by Professor Vocadlo and Professor Davies is not yet a drug, but it is a major breakthrough in finding compounds that cross the blood-brain barrier to elicit beneficial effects that prevent the onset of tauopathies.

Professor Davies, of the Department of Chemistry at York, said: "We hope that the work will evolve into new drugs to treat Alzheimer's disease, although that is still many years off. The work highlights the synergy of studying the chemistry of enzymes in living cells."

The York /Simon Fraser collaboration also revealed the first structure of the enzyme responsible for the installation of these protective sugars in a paper in Nature Structural & Molecular Biology earlier this month.

YORK UNIVERSITY
Heslington
York
YO10 5DD
http://www.york.ac.uk

Article adapted by Medical News Today from original press release.
Visit our alzheimer's / dementia section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
YORK UNIVERSITY. "Brain 'trick' Offers Treatment Hope For Alzheimer's." Medical News Today. MediLexicon, Intl., 3 Jul. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/113760.php>

APA
YORK UNIVERSITY. (2008, July 3). "Brain 'trick' Offers Treatment Hope For Alzheimer's." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/113760.php.

Please note: If no author information is provided, the source is cited instead.


Alzheimer's / Dementia

What Is Alzheimer's Disease?

Alzheimer's disease is a progressive neurologic disease of the brain leading to the irreversible loss of neurons and the loss of intellectual abilities, including memory and reasoning. Read more...

What is Dementia?

The word dementia comes from the Latin de meaning "apart" and mens from the genitive mentis meaning "mind". Dementia is the progressive deterioration in cognitive function - the ability to process thought (intelligence). Read more...

Most Popular Articles



Follow Our Alzheimer's News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Alzheimer's / Dementia Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »